CC
SLDB icon

Corsicana & Co’s Solid Biosciences SLDB Stock Holding History

Corsicana & Co’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1K Hold
6
– – ﹤0.01% 205
2022
Q2 		$1K Hold
6
– – ﹤0.01% 208
2022
Q1 		$1K Hold
6
– – ﹤0.01% 210
2021
Q4 		$1K Sell
6
-267
-98% -$8.16K ﹤0.01% 207
2021
Q3 		$10K Hold
273
– – 0.01% 179
2021
Q2 		$15K Buy
+273
New +$18K 0.01% 168

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Corsicana & Co's SLDB Position: Q3 2022 in Review

Corsicana & Co held its Solid Biosciences (SLDB) position steady in Q3 2022 at 6 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #205.

Corsicana & Co first reported a position in SLDB in Q2 2021 and has held it in 6 quarters since. The position peaked at $15K in Q2 2021. 58 funds tracked by Wall St. Rank hold SLDB as of Q3 2022.

  • Corsicana & Co held 6 shares of Solid Biosciences worth $1K as of Q3 2022.
  • Corsicana & Co left its Solid Biosciences share count unchanged in Q3 2022.
  • Solid Biosciences made up ﹤0.01% of Corsicana & Co's portfolio in Q3 2022, its #205 holding.
  • Corsicana & Co first reported a position in Solid Biosciences in Q2 2021 and has held it in 6 quarters since.
  • Corsicana & Co's Solid Biosciences position peaked at $15K in Q2 2021.
  • 58 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2022.

Based on Corsicana & Co's 13F filing for Q3 2022, filed 14 Oct 2022.